S100B and early-onset autosomal dominant Alzheimer disease: Chromosomal rearrangement and expression changes of S100B gene have been verified to be related to several nervous system diseases, neoplastic diseases, endocrine diseases like Alzheimer’s disease (AD), Down’s syndrome, epilepsy, amyotrophic lateralizing sclerosis, tumor and type 1 diabetes (38, 39).